InvestorsHub Logo
Followers 30
Posts 5082
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Saturday, 10/24/2020 1:13:28 PM

Saturday, October 24, 2020 1:13:28 PM

Post# of 427500
Old timers here will know story's like this one - but for many latecomers like me - it's interesting to learn about the story of also Lovaza - which seem to be linked to Amarin - the two drugs both aimed at lowering trigs - at that point in 2014.

I did not know that Lovaza is in fact a GSK product - released as early as 2004. In link below - Teva have just gotten FDA aproval for a generic Lovaza 2014 (Amarin also effected/mentioned).

http://www.pmlive.com/pharma_news/teva_launches_first_generic_of_gsks_lovaza_in_us_559273
-------------------

To finish history input - here something to cbb's (and others) augments - that company should have been sold - BO - after Approval December 2019. This article says the same at the bottom section.

http://www.pmlive.com/pharma_news/fda_okays_amarins_vascepa_for_cardiovascular_risk_reduction_1320205
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News